酒さ(Rosacea):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Rosacea Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2724CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年6月16日
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における酒さ(Rosacea) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 酒さ(Rosacea)
  - 当レポートの概要
・酒さ(Rosacea):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Rosacea Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Rosacea Global Clinical Trials Review, H1, 2015″ provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Rosacea 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Rosacea 22
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Rosacea Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Nestle S.A. 30
Clinical Trial Overview of Nestle S.A. 30
Actavis plc 32
Clinical Trial Overview of Actavis plc 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Valeant Pharmaceuticals International, Inc. 34
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 34
Galderma S.A. 35
Clinical Trial Overview of Galderma S.A. 35
DermResearch, Inc. 36
Clinical Trial Overview of DermResearch, Inc. 36
La Roche-Posay Pharmaceutical Laboratories 37
Clinical Trial Overview of La Roche-Posay Pharmaceutical Laboratories 37
Amorepacific Corporation 38
Clinical Trial Overview of Amorepacific Corporation 38
Derm Research, PLLC 39
Clinical Trial Overview of Derm Research, PLLC 39
Celgene Corporation 40
Clinical Trial Overview of Celgene Corporation 40
Clinical Trial Overview of Top Institutes / Government 41
Academic Medical Center 41
Clinical Trial Overview of Academic Medical Center 41
Centre Hospitalier Universitaire de Nice 42
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 42
Columbia University 43
Clinical Trial Overview of Columbia University 43
Essentia Health 44
Clinical Trial Overview of Essentia Health 44
Loyola University Health Center 45
Clinical Trial Overview of Loyola University Health Center 45
Massachusetts General Hospital 46
Clinical Trial Overview of Massachusetts General Hospital 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Medical Research Institute of New Zealand 48
Clinical Trial Overview of Medical Research Institute of New Zealand 48
National Taiwan University Hospital 49
Clinical Trial Overview of National Taiwan University Hospital 49
Northwestern University 50
Clinical Trial Overview of Northwestern University 50
Five Key Clinical Profiles 51
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80

List of Tables
Rosacea Therapeutics, Global, Clinical Trials by Region, 2015* 7
Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Rosacea Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Rosacea Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Rosacea Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Rosacea Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23
Rosacea Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015* 30
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 32
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 34
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2015* 35
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by DermResearch, Inc., 2015* 36
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by La Roche-Posay Pharmaceutical Laboratories, 2015* 37
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Amorepacific Corporation, 2015* 38
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Derm Research, PLLC, 2015* 39
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 40
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 41
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2015* 42
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 43
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Essentia Health, 2015* 44
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Loyola University Health Center, 2015* 45
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 46
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 47
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Institute of New Zealand, 2015* 48
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 49
Rosacea Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 50

List of Figures
Rosacea Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Rosacea Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Rosacea Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 79

【掲載企業】

Nestle S.A.
Actavis plc
Bayer AG
Valeant Pharmaceuticals International, Inc.
Galderma S.A.
DermResearch, Inc.
La Roche-Posay Pharmaceutical Laboratories
Amorepacific Corporation
Derm Research, PLLC
Celgene Corporation

【レポートのキーワード】

酒さ(Rosacea)、治験、臨床試験、治験、治療薬

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[酒さ(Rosacea):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆